Join us for an exclusive scientific webinar about one of the most studied medicinal plants in the world, Echinacea purpurea. Learn about innovative pharmacological discoveries and clinical data demonstrating its role in preventing and managing respiratory tract infections.
This event is designed for pharmacists and healthcare professionals who want to expand their knowledge about how Echinacea provides a safe, plant-based remedy that strengthens immunity and promotes human health, in adults and children.
Agenda
Echinacea in Focus: Towards Mechanisms of Action - Prof. WimVanden Berghe
Echinaforce® for RTIs: Efficacy, Safety, and Practical Use - Dr. Mercedes Ogal
Presenters
Prof. Wim Vanden Berghe
Epigenetic Signaling Lab, PPES, University Antwerp, Belgium
Prof. Wim Vanden Berghe obtained his PhD in Biochemistry-Biotechnology at the University of Ghent in 1999. After postdoctoral research at the University of Montpellier, Stellenbosch and Oxford, he was appointed professor of Epigenetics in 2009 at the lab for Protein chemistry, proteomics and epigenetic signaling (PPES, Universities of Antwerp and Gent, Belgium). With his current research, he is characterizing epigenetic regulation of kinase signaling pathways to modulate inflammatory disease phenotypes with phytomedicinal or pharmacological compounds in cancer, atherosclerosis, obesity, infectious disease or neurodegeneration.
Mercedes Ogal has worked as a specialized integrative paediatrician for 14 years in a pediatric medical practice in Central Switzerland. She developed her deep knowledge in complementary medicine since 1991 in phytotherapy, acupuncture, homoepathy, medical hypnosis and orthomolecular medicine and owns certificates in various medicinal disciplines. Furthermore, Dr. Mercedes Ogal is author of publications and speaker on various national and international lectures and conferences.
Dr. Roland Schoop
Head of Medical Department A.Vogel, Switzerland
Dr. Roland Schoop is Head of Medical Department at A.Vogel AG in Roggwil, Switzerland. He holds a degree in biochemistry and immunology and graduated at the University of Westminster (UK). His research focuses on the pharmacology and clinical efficacy of Echinacea purpurea (Echinaforce®) in viral pathology and respiratory infections. He has (co‑)authored multiple randomized controlled trials, scientific reviews and pharmacological studies on standardized Echinacea preparations. His broader aim is to integrate the principles of rational phytotherapy within the framework of classical evidence‑based medicine.